Vanguard Global Advisers
HCAT icon

Vanguard Global Advisers’s Health Catalyst HCAT Stock Holding History

Vanguard Global Advisers’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71K Sell
35,683
-137,481
-79% -$198K ﹤0.01% 2942
2026
Q1 		$220K Buy
+173,164
New +$326K ﹤0.01% 2400

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Global Advisers's HCAT Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Health Catalyst (HCAT) stake by 79% in Q2 2026, selling an estimated $198K and leaving 35,683 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #2942.

Vanguard Global Advisers first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $220K in Q1 2026. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Vanguard Global Advisers held 35,683 shares of Health Catalyst worth $71K as of Q2 2026.
  • Vanguard Global Advisers sold 137,481 Health Catalyst shares in Q2 2026, an estimated $198K.
  • Health Catalyst made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2942 holding.
  • Vanguard Global Advisers first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Health Catalyst position peaked at $220K in Q1 2026.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.